Yoffe Investment Management LLC Makes New $542,000 Investment in Johnson & Johnson (NYSE:JNJ)

Yoffe Investment Management LLC acquired a new stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,748 shares of the company's stock, valued at approximately $542,000.

Several other large investors also recently made changes to their positions in JNJ. Tallon Kerry Patrick bought a new stake in Johnson & Johnson during the fourth quarter worth $290,000. Capital & Planning LLC boosted its holdings in Johnson & Johnson by 13.6% during the 4th quarter. Capital & Planning LLC now owns 1,528 shares of the company's stock worth $221,000 after acquiring an additional 183 shares during the last quarter. Cetera Trust Company N.A grew its stake in shares of Johnson & Johnson by 13.5% in the 4th quarter. Cetera Trust Company N.A now owns 1,923 shares of the company's stock worth $278,000 after acquiring an additional 229 shares in the last quarter. Westside Investment Management Inc. lifted its position in shares of Johnson & Johnson by 13.3% during the fourth quarter. Westside Investment Management Inc. now owns 4,859 shares of the company's stock valued at $703,000 after purchasing an additional 570 shares in the last quarter. Finally, Kelleher Financial Advisors boosted its holdings in Johnson & Johnson by 2.6% during the fourth quarter. Kelleher Financial Advisors now owns 6,516 shares of the company's stock worth $942,000 after purchasing an additional 165 shares during the last quarter. 69.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on JNJ shares. Wall Street Zen cut shares of Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of Johnson & Johnson in a research report on Wednesday, April 16th. Barclays cut their price objective on Johnson & Johnson from $166.00 to $165.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Leerink Partnrs lowered Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, May 13th. Finally, Benchmark raised shares of Johnson & Johnson to a "strong-buy" rating in a report on Thursday, April 24th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $170.88.

Johnson & Johnson Price Performance

JNJ stock traded up $0.53 during mid-day trading on Thursday, reaching $152.96. 2,353,932 shares of the company traded hands, compared to its average volume of 7,931,169. Johnson & Johnson has a 52-week low of $140.68 and a 52-week high of $169.99. The company has a market capitalization of $368.04 billion, a P/E ratio of 23.00, a P/E/G ratio of 2.56 and a beta of 0.42. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.11 and a quick ratio of 0.86. The company has a fifty day moving average price of $154.63 and a 200-day moving average price of $153.64.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last issued its quarterly earnings data on Tuesday, April 15th. The company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.59 by $0.18. Johnson & Johnson had a return on equity of 34.24% and a net margin of 18.20%. The company had revenue of $21.89 billion for the quarter, compared to the consensus estimate of $21.65 billion. As a group, analysts anticipate that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 27th will be given a $1.30 dividend. This is an increase from Johnson & Johnson's previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Tuesday, May 27th. This represents a $5.20 dividend on an annualized basis and a yield of 3.40%. Johnson & Johnson's payout ratio is presently 57.84%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.